-
Article | 2025.02.20
MD-PhD Program
The Institut Pasteur MD-PhD program is designed to bridge the gap between fundamental, applied research and clinical practice, equipping physicians with the skills needed to tackle the increasingly complex healthcare challenges of today. This program offers opportunities for medical students and doctors to improve patient care and in parallel foster innovation in medical sciences.
-
News | 2025.04.22
Tecovirimat is an effective treatment for mpox
The antiviral drug tecovirimat is frequently used to treat mpox. But is it really effective, especially against the new, more pathogenic strain of the virus that has been in circulation since 2024? A study by the Institut Pasteur, recently published in The Lancet Infectious Diseases (1), concludes that it is.
-
Article | 2017.01.04
Pasteur-Cnam-EHESP School of Public Health
The Institut Pasteur and the Cnam (National Conservatory of Arts and Crafts), in partnership with the EHESP (French School of Public Health), have combined their complementary expertise within the Pasteur-Cnam-EHESP School of Public Health to offer an Advanced Master degree - Mastère Spécialisé in Public Health.
-
Vidéo | 2025.04.24
Goodbye allergic asthma?
Every spring, the same battle: allergic asthma poisons the lives of millions of people.This form of asthma, triggered by allergens such as pollen, dust mites or animal hair, accounts for around 50% of asthma cases worldwide.As well as causing respiratory discomfort, it has a lasting impact on quality of life, and remains difficult to control, particularly in its severe forms.Today, the treatments...
-
Vidéo | 2025.04.25
How does physics reveal the secrets of life ?
Diving into the invisible: when physics reveals the secrets of life These hypnotic images of dividing bacteria are more than just aesthetic: they are at the heart of research carried out by Gautham Sankara Narayana, a biophysics researcher in the Duménil laboratory at the Institut Pasteur, as part of the Bonazzi team. Using confocal microscopy and computational analysis tools, he is...
-
Article | 2025.02.07
International support
International support is crucial to our success
-
Report | 2024.12.11
The history of mpox: from the very first cases to new findings
The first cases of mpox were observed in the Democratic Republic of Congo in 1970, then spread to a number of other African countries. In the Central African Republic, the first case was recorded in the 1980s, in a family living in the south-west of the country. The Institut Pasteur de Bangui monitored this case and the subsequent ones, and has since developed expertise on the disease,...
-
Article | 2025.04.28
Lettre de l'Institut Pasteur - International
Find all the publication archives of La lettre de l'Institut Pasteur
-
News | 2025.04.29
Advanced HPV RNA-Seq Test developed by the Institut Pasteur : exclusive license signed with ABL Diagnostics
The Institut Pasteur, a Carnot institute since 2007, and ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, recently signed a licensing agreement for the integration of the innovative HPV RNA sequencing technology into ABL Diagnostics solutions, which will produce and market the test.HPV RNA-Seq is a cutting-edge diagnostic method that enhances the detection and typing of high-...
-
Document de presse | 2025.04.28
HIV: genetic characteristics associated with sustained HIV remission after stopping treatment
Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment. But some individuals, known as "post-treatment controllers," are able to maintain an undetectable viral load even after stopping treatment. In a study funded by ANRS Emerging Infectious Diseases (ANRS...
